Tigermed takes $50M stake in U.S. CRO; Accovion restructures operations;

> Chinese CRO Tigermed has wrapped up its acquisition of a $50 million share of the U.S.'s Frontage Laboratories. Release

> Contract manufacturer PCI has agreed to buy U.K. drug developer Penn Pharmaceutical Services for an undisclosed sum. Story

> German CRO Accovion has restructured its operations, dividing its growing business between Western, Central, Eastern and Southeastern Europe. Release

Suggested Articles

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.